0001209191-17-060386.txt : 20171113
0001209191-17-060386.hdr.sgml : 20171113
20171113172639
ACCESSION NUMBER: 0001209191-17-060386
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20171103
FILED AS OF DATE: 20171113
DATE AS OF CHANGE: 20171113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duffy Erin
CENTRAL INDEX KEY: 0001722489
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35405
FILM NUMBER: 171197273
MAIL ADDRESS:
STREET 1: C/O MELINTA THERAPEUTICS, INC.
STREET 2: 300 GEORGE STREET, SUITE 301
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MELINTA THERAPEUTICS, INC. /NEW/
CENTRAL INDEX KEY: 0001461993
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262644445
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6320 QUADRANGLE DRIVE
STREET 2: SUITE 360
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517-8149
BUSINESS PHONE: 919-576-2306
MAIL ADDRESS:
STREET 1: 6320 QUADRANGLE DRIVE
STREET 2: SUITE 360
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517-8149
FORMER COMPANY:
FORMER CONFORMED NAME: CEMPRA, INC.
DATE OF NAME CHANGE: 20120203
FORMER COMPANY:
FORMER CONFORMED NAME: Cempra Holdings, LLC
DATE OF NAME CHANGE: 20090414
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2017-11-03
0
0001461993
MELINTA THERAPEUTICS, INC. /NEW/
MLNT
0001722489
Duffy Erin
C/O MELINTA THERAPEUTICS, INC.
300 GEORGE STREET, SUITE 301
NEW HAVEN
CT
06511
0
1
0
0
Chief Scientific Officer
Stock Option (Right to Buy)
17.04
2023-12-16
Common Stock
23213
D
Stock Option (Right to Buy)
27.52
2024-04-07
Common Stock
19853
D
Stock Option (Right to Buy)
36.25
2025-08-31
Common Stock
8108
D
Stock Option (Right to Buy)
20.97
2027-08-07
Common Stock
4692
D
Stock Option (Right to Buy)
27.52
2024-04-07
Common Stock
1145
I
By Spouse
Stock Option (Right to Buy)
20.97
2027-08-07
Common Stock
1145
I
By Spouse
The option is fully vested.
The option vests 1/4 on April 8, 2015 and 1/48 every month thereafter.
The option vests 1/4 on September 9, 2016 and 1/48 every month thereafter.
The option vests 1/4 on August 8, 2018 and 1/48 every month thereafter.
/s/ Alexander M. Donaldson, by Power of Attorney
2017-11-13
EX-24.3_751743
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints each of Kenneth E. Eheman, Alexander M. Donaldson and S. Halle Vakani,
and each of them acting alone, signing singly, the undersigned's true and lawful
attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer, director and/or 10% or more stockholder of
Melinta Therapeutics, Inc. (the "Company"), Forms 3, 4 and 5, and Update
Passphrase Acknowledgement (and any amendments thereto) in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended (the "1934
Act"), and the rules promulgated thereunder; (2) do and perform any and all acts
for and on behalf of the undersigned which may be necessary or desirable to
complete and execute any such Form 3, 4 and 5, and Update Passphrase
Acknowledgement (and any amendments thereto) and to file timely such form with
the United States Securities and Exchange Commission and any stock exchange or
similar authority; and (3) take any other action of any type whatsoever in
connection with the foregoing which in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney
shall be in such form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the 1934 Act.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5, and Update
Passphrase Acknowledgement with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the
undersigned, in a signed writing delivered to each of the foregoing
attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 8th day of November 2017.
/s/ Erin Duffy
Erin Duffy, Ph.D.